IO Biotech Inc


Download Data

IO Biotech Inc Market Capitalization on April 17, 2024: USD 98.82 M

IO Biotech Inc Market Capitalization is USD 98.82 M on April 17, 2024, a 38.91% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.
  • IO Biotech Inc 52-week high Market Capitalization is USD 133.74 M on August 16, 2023, which is 35.33% above the current Market Capitalization.
  • IO Biotech Inc 52-week low Market Capitalization is USD 125.35 K on February 29, 2024, which is -99.87% below the current Market Capitalization.
  • IO Biotech Inc average Market Capitalization for the last 52 weeks is USD 96.28 M.

IO Biotech Inc

CEO Dr. Mai-Britt Zocca Ph.D.
IPO Date Nov. 5, 2021
Location Denmark
Headquarters Ole Maaløes Vej 3, Copenhagen, Denmark, 2200
Employees 68
Sector Healthcare
Industry Biotechnology

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.

Similar companies


Eliem Therapeutics Inc

USD 4.56



MediciNova Inc

USD 1.52



Century Therapeutics Inc

USD 3.14



Lyra Therapeutics Inc

USD 5.40



Monte Rosa Therapeutics Inc

USD 6.06



Cullinan Oncology LLC

USD 17.32



Compass Therapeutics Inc.

USD 1.57



Design Therapeutics Inc

USD 3.69



Werewolf Therapeutics Inc

USD 5.61



Stoke Therapeutics Inc

USD 12.45


StockViz Staff

April 18, 2024

Any question? Send us an email